Patents by Inventor Christopher M. Haggerty

Christopher M. Haggerty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230343464
    Abstract: A method for determining cardiology disease risk from electrocardiogram trace data and clinical data includes receiving electrocardiogram trace data associated with a patient, receiving the patient's clinical data, providing both sets of data to a trained machine learning composite model that is trained to evaluate the data with respect to each disease of a set of cardiology diseases including three or more of cardiac amyloidosis, aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, abnormal reduced ejection fraction, or abnormal interventricular septal thickness, generating, by the model and based on the evaluation, a composite risk score reflecting a likelihood of the patient being diagnosed with one or more of the cardiology diseases within a predetermined period of time from when the electrocardiogram trace data was generated, and outputting the composite risk score to at least one of a memory or a display.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 26, 2023
    Inventors: Alvaro E. Ulloa-Cerna, Noah Zimmerman, Greg Lee, Christopher M. Haggerty, Brandon K. Fornwalt, Ruijun Chen, John Pfeifer, Christopher Good
  • Patent number: 11756688
    Abstract: A method for determining cardiology disease risk from electrocardiogram trace data and clinical data includes receiving electrocardiogram trace data associated with a patient, receiving the patient's clinical data, providing both sets of data to a trained machine learning composite model that is trained to evaluate the data with respect to each disease of a set of cardiology diseases including three or more of cardiac amyloidosis, aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, abnormal reduced ejection fraction, or abnormal interventricular septal thickness, generating, by the model and based on the evaluation, a composite risk score reflecting a likelihood of the patient being diagnosed with one or more of the cardiology diseases within a predetermined period of time from when the electrocardiogram trace data was generated, and outputting the composite risk score to at least one of a memory or a display.
    Type: Grant
    Filed: May 31, 2022
    Date of Patent: September 12, 2023
    Assignees: Tempus Labs, Inc., Geisinger Clinic
    Inventors: Alvaro E. Ulloa-Cerna, Noah Zimmerman, Greg Lee, Christopher M. Haggerty, Brandon K. Fornwalt, Ruijun Chen, John Pfeifer, Christopher Good
  • Publication number: 20220384044
    Abstract: A method for determining cardiology disease risk from electrocardiogram trace data and clinical data includes receiving electrocardiogram trace data associated with a patient, receiving the patient's clinical data, providing both sets of data to a trained machine learning composite model that is trained to evaluate the data with respect to each disease of a set of cardiology diseases including three or more of cardiac amyloidosis, aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, abnormal reduced ejection fraction, or abnormal interventricular septal thickness, generating, by the model and based on the evaluation, a composite risk score reflecting a likelihood of the patient being diagnosed with one or more of the cardiology diseases within a predetermined period of time from when the electrocardiogram trace data was generated, and outputting the composite risk score to at least one of a memory or a display.
    Type: Application
    Filed: May 31, 2022
    Publication date: December 1, 2022
    Inventors: Alvaro E. Ulloa-Cerna, Noah Zimmerman, Greg Lee, Christopher M. Haggerty, Brandon K. Fomwalt, Ruijun Chen, John Pfeifer, Chris Good